AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metraff-G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Raffles Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Metraff-G2 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation without medical consultation can elevate blood glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate management. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is crucial, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Metraff-G2 Tablet SR

The provided text is "undefined," offering no content to rephrase.

Uses of Metraff-G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Metraff-G2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Metraff-G2 Tablet SR with a meal.

Common Side effects of Metraff-G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metraff-G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metraff-G2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Metraff-G2 Tablet SR works:

Glimepiride and Metformin, the active components of Metraff-G2 SR tablets, offer a dual approach to blood sugar management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metraff-G2 Tablet SR and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metraff-G2 tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Metraff-G2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metraff-G2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Metraff-G2 Tablet SR use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Metraff-G2 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Metraff-G2 Tablet SR :

Should you forget a Metraff-G2 Tablet SR dose, take it immediately. However, near the time for your next scheduled dose, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Metraff-G2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Metraff-G2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metraff-G2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metraff-G2 Tablet SR and seek immediate medical attention.
Metraff-G2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Metraff-G2 Tablet SR may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Metraff-G2 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Metraff-G2 Tablet SR can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metraff-G2 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Metraff-G2 Tablet SR
58
MRP 67
13% off